Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Mentor Finds Prospective Buyer For Urology Business In Coloplast

This article was originally published in The Gray Sheet

Executive Summary

Mentor signaled March 27 that it has found a buyer for its urology business, furthering its shift to aesthetics medicine

You may also be interested in...



Mentor Seeks Aesthetic Medicine Acquisitions For Near-Term Growth

Mentor says it is on the lookout for acquisitions and licensing deals in the aesthetics arena as it waits to see if FDA will approve its silicone breast implants

Mentor Seeks Aesthetic Medicine Acquisitions For Near-Term Growth

Mentor says it is on the lookout for acquisitions and licensing deals in the aesthetics arena as it waits to see if FDA will approve its silicone breast implants

Mentor almost free of urology

Firm announces definitive agreement to sell its Surgical Urology and Clinical and Consumer Healthcare divisions to Coloplast for $463 mil. on May 17. The transaction will enable Mentor to focus on the development of its aesthetics business (1"The Gray Sheet" April 3, 2006, p. 7). Mentor also reported that it has initiated a four-month Phase 1 study of its botulinum toxin type A product to treat pain associated with adult onset spasmodic torticollis/cervical dystonia...

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

MT023395

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel